BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
Daiichi Sankyo
US Army
Express Scripts
Farmers Insurance

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088167

« Back to Dashboard

NDA 088167 describes FLUOCINOLONE ACETONIDE, which is a drug marketed by Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs, Perrigo New York, Pharmaderm, Pharmafair, Taro, Usl Pharma, Akorn, Identi Pharms Inc, Lyne, Perrigo Israel, Actavis Labs Ut Inc, Bausch And Lomb, G And W Labs Inc, Gavis Pharms Llc, and Morton Grove, and is included in forty-six NDAs. It is available from fourteen suppliers. Additional details are available on the FLUOCINOLONE ACETONIDE profile page.

The generic ingredient in FLUOCINOLONE ACETONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 088167
Pharmacology for NDA: 088167
Medical Subject Heading (MeSH) Categories for 088167
Suppliers and Packaging for NDA: 088167
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 088167 ANDA E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. 0168-0059 0168-0059-60 60 mL in 1 BOTTLE (0168-0059-60)
FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 088167 ANDA Physicians Total Care, Inc. 54868-2264 54868-2264-1 1 BOTTLE in 1 CARTON (54868-2264-1) > 60 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;TOPICALStrength0.01%
Approval Date:Dec 16, 1982TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.